Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-Î³ agonists

Article ID	Journal	Published Year	Pages	File Type
5588541	Metabolism	2017	15 Pages	PDF

Keywords

RCT patatin-like phospholipase domain-containing protein PNPLA NAFLD LVMI LVH T2DM HDL-C NAS PPAR HOMA-IR LDL-C Randomized controlled trial simple steatosis nonalcoholic steatohepatitis cardiovascular disease Nonalcoholic fatty liver disease Type 2 diabetes mellitus CVD Metabolic syndrome Left ventricular mass index high-density lipoprotein cholesterol METS Insulin resistance hazard ratio odds ratio NAFLD activity score Nash Left ventricular hypertrophy Low-density lipoprotein cholesterol Peroxisome proliferator activated receptor

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology

Authors

Stergios A. Polyzos, Elisabetta Bugianesi, Jannis Kountouras, Christos S. Mantzoros,